Drug Profile
Idronoxil
Alternative Names: Dehydroequol; NV 06; Phenoxodiol; PXDLatest Information Update: 24 Sep 2021
Price :
$50
*
At a glance
- Originator Novogen
- Developer MEI Pharma
- Class Anti-infectives; Anti-inflammatories; Antineoplastics; Antivirals; Hormones; Isoflavones; Small molecules
- Mechanism of Action Caspase stimulants; NADH oxidase inhibitors; Proto oncogene protein c-akt inhibitors; X-linked inhibitor of apoptosis protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Autoimmune disorders; Benign prostatic hyperplasia; Fallopian tube cancer; Leukaemia; Ovarian cancer; Precursor cell lymphoblastic leukaemia-lymphoma; Prostate cancer; Renal cancer; Skin cancer; Transplant rejection